FDA Drug Application (012945) for DIAMOX by TEVA BRANDED PHARM

Back to FDA Applications sponsored by TEVA BRANDED PHARM

Application Number012945
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage500MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDIAMOX
Active IngredientACETAZOLAMIDE

Active IngredientCount
List of drugs with Active Ingredient ACETAZOLAMIDE2
List of drugs with Active Ingredient ACETAZOLAMIDE SODIUM2


Back to FDA Applications sponsored by TEVA BRANDED PHARM